Hostile takeovers/buyouts happen more and more these days and what is the value of PS Targeting patents if Immunotherapy becomes a $200Billion industry per year within 5 years? Now imagine PS Targeting having a percent of that $200 Billion figure... Hmmmm
It would be nice I guess BUT since we are more than 5 years from getting FDA permission to sell something I guess we can just watch someone else make money.